Home >> Law >> Food & Beverage >>

Avaxia Biologics, Inc. - Product Pipeline Review - 2015

Published: May-2015 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 19833

Avaxia Biologics, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Avaxia Biologics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Avaxia Biologics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Avaxia Biologics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Avaxia Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Avaxia Biologics, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Avaxia Biologics, Inc.’s pipeline products

Reasons to buy

- Evaluate Avaxia Biologics, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Avaxia Biologics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Avaxia Biologics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Avaxia Biologics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Avaxia Biologics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Avaxia Biologics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Avaxia Biologics, Inc. Snapshot 4
Avaxia Biologics, Inc. Overview 4
Key Information 4
Key Facts 4
Avaxia Biologics, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Avaxia Biologics, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Avaxia Biologics, Inc. - Pipeline Products Glance 9
Avaxia Biologics, Inc. - Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Avaxia Biologics, Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Avaxia Biologics, Inc. - Drug Profiles 12
AVX-470 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
AVX-176 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Antibody for Obesity and Type II Diabetes 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Avaxia Biologics, Inc. - Pipeline Analysis 15
Avaxia Biologics, Inc. - Pipeline Products by Target 15
Avaxia Biologics, Inc. - Pipeline Products by Route of Administration 16
Avaxia Biologics, Inc. - Pipeline Products by Molecule Type 17
Avaxia Biologics, Inc. - Pipeline Products by Mechanism of Action 18
Avaxia Biologics, Inc. - Recent Pipeline Updates 19
Avaxia Biologics, Inc. - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables
Avaxia Biologics, Inc., Key Information 4
Avaxia Biologics, Inc., Key Facts 4
Avaxia Biologics, Inc. - Pipeline by Indication, 2015 6
Avaxia Biologics, Inc. - Pipeline by Stage of Development, 2015 7
Avaxia Biologics, Inc. - Monotherapy Products in Pipeline, 2015 8
Avaxia Biologics, Inc. - Phase I, 2015 9
Avaxia Biologics, Inc. - Preclinical, 2015 10
Avaxia Biologics, Inc. - Discovery, 2015 11
Avaxia Biologics, Inc. - Pipeline by Target, 2015 15
Avaxia Biologics, Inc. - Pipeline by Route of Administration, 2015 16
Avaxia Biologics, Inc. - Pipeline by Molecule Type, 2015 17
Avaxia Biologics, Inc. - Pipeline Products by Mechanism of Action, 2015 18
Avaxia Biologics, Inc. - Recent Pipeline Updates, 2015 19

List of Figures
Avaxia Biologics, Inc. - Pipeline by Top 10 Indication, 2015 6
Avaxia Biologics, Inc. - Pipeline by Stage of Development, 2015 7
Avaxia Biologics, Inc. - Monotherapy Products in Pipeline, 2015 8
Avaxia Biologics, Inc. - Pipeline by Top 10 Target, 2015 15
Avaxia Biologics, Inc. - Pipeline by Top 10 Route of Administration, 2015 16
Avaxia Biologics, Inc. - Pipeline by Top 10 Molecule Type, 2015 17
Avaxia Biologics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 18

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing